My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

87.47 -3.21 (-3.54%)

Streaming Delayed Price Updated: 10:44 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗

October 28, 2025

GeneDx Q3 2025 earnings crush estimates with 52% revenue growth. Strong exome/genome test demand and raised 2025 guidance fuel investor optimism.

Via Chartmill

Topics Earnings

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

GeneDx Hldgs's Earnings: A Preview ↗

October 27, 2025

Via Benzinga

4 Analysts Assess GeneDx Holdings: What You Need To Know ↗

October 20, 2025

Via Benzinga

This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

October 20, 2025

Via Benzinga

GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case ↗

October 14, 2025

GeneDx stock shows strong growth momentum with 600% EPS growth and a bullish technical setup, signaling a potential breakout for investors.

Via Chartmill

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Exploring GeneDx Hldgs's Earnings Expectations ↗

July 28, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2025

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Positive Technical Setup ↗

September 22, 2025

GeneDx (WGS) shows explosive growth with 600% EPS growth and a strong technical uptrend, making it a top high-growth momentum stock for investors.

Via Chartmill

Assessing GeneDx Holdings: Insights From 5 Financial Analysts ↗

September 11, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

Why GeneDx Holdings Stock Crushed It Again Today ↗

July 30, 2025

It continued to ride high on its solid second-quarter performance.

Via The Motley Fool

What 4 Analyst Ratings Have To Say About GeneDx Holdings ↗

July 30, 2025

Via Benzinga

Why GeneDx Holdings Stock Blasted 8% Higher Today ↗

July 29, 2025

There's nothing like a crushing double beat on quarterly results to give some life to a stock.

Via The Motley Fool

Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday ↗

July 29, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

July 29, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 29, 2025

Via Benzinga

GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Technical Strength for Potential Upside ↗

July 29, 2025

GeneDx Holdings Corp (WGS) shows strong earnings & revenue growth, positive analyst revisions, and solid technicals, making it a high-growth momentum stock with breakout potential.

Via Chartmill

GeneDx CFO Sells More Than Half of His Shares ↗

July 25, 2025

Via The Motley Fool

Topics Artificial Intelligence

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains ↗

June 30, 2025

With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?

Via MarketBeat

Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts ↗

June 30, 2025

Via Benzinga

Why GeneDX Stock Surged Higher This Week ↗

June 27, 2025

Via The Motley Fool

Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days ↗

June 24, 2025

There's a new recommendation on genetic testing for children, and this stock is on the rise.

Via Investor's Business Daily

Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday ↗

June 24, 2025

Via Benzinga

Analyst Expectations For GeneDx Holdings's Future ↗

May 09, 2025

Via Benzinga

This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday ↗

May 09, 2025

Via Benzinga

Why Investors Were Avoiding GeneDx Holdings Stock This Week ↗

May 02, 2025

Via The Motley Fool

Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat ↗

April 30, 2025

GeneDx shares plunged 43% despite strong Q1 results and raised guidance, drawing a surge in retail investor interest. The drop followed the company's first sequential test volume decline, which it...

Via Stocktwits

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.